Advertising

Grand Prix drought ends, but questions persist

Grand Prix drought ends, but questions persist

By

The inspirational value is clear for Lions Health attendees, but there is still confusion about what good looks like for branded pharma campaigns, and how the US fits in.

Pharma at Cannes:  C'est la Vie

Pharma at Cannes: C'est la Vie

By

It's not only a venue to gain creative inspiration, but a good place to scout talent, and there are no lack of strategic meetings underway in Cannes.

Mullen Lowe's Sokoloff closes Lions Health

By

The second annual Lions Health creativity festival ended Saturday.

19 US entries shortlisted at Lions Health

19 US entries shortlisted at Lions Health

By

The Lions Health award winners will be announced later Friday at an event in Cannes, France.

Five things for pharma marketers to know: Thursday, June 18

Five things for pharma marketers to know: Thursday, June 18

By

Merck settles a marketing lawsuit for $5.9 million; CVS plans to create diagnostic apps; a survey shows advertising agencies plan to keep head count steady for the rest of the year

Pioneering info portal for doctors turns 20

Pioneering info portal for doctors turns 20

By

Medscape marked its 20th anniversary with a reunion this week that attracted staffers from the portal's earliest days.

Pfizer's "Get Old" campaign gets youthful

Pfizer's "Get Old" campaign gets youthful

By

The three-year-old campaign's youthful tone evolves as its audience ages.

DTC expected to propel Afrezza awareness, not necessarily sales

DTC expected to propel Afrezza awareness, not necessarily sales

By

Havas Health developed the inhaled insulin's advertising campaign, which is slated to kick off later this summer.

Cannes Grand Prix may again prove elusive for pharma

Cannes Grand Prix may again prove elusive for pharma

By

The Lions Health jurors in 2014 declined to award the top prize in the pharma category, raising questions about how the industry's creativity stacks up against the world's top marketers.

A Q&A with Rob Rogers, 2015 Lions Health pharma jury president

A Q&A with Rob Rogers, 2015 Lions Health pharma jury president

By

He spoke with MM&M about whether pharma is ready to win a Grand Prix, if regulation limits creativity in healthcare, and why wearables may spur creativity.

Five things for pharma marketers to know: Friday, May 22

Five things for pharma marketers to know: Friday, May 22

By

Amgen's PSCK9 inhibitor gets a position opinion in the EU; the FDA plans to study how spouses influence perception of DTC ads; Botox may relieve depression

Centron scuttles HealthStar name, sells LehmanMillet

Centron scuttles HealthStar name, sells LehmanMillet

By

The new Centron includes renamed medical education, public relations and market access divisions.

Everyday Health looks to compete for pharma TV budgets

Everyday Health looks to compete for pharma TV budgets

By

The digital health firm is expanding services to pharma customers, offering to help drugmakers maximize spending on TV and video.

WebMD profit jumps 60% in the first quarter

WebMD profit jumps 60% in the first quarter

By

The company said revenue from pharmaceutical and medical device sponsorships and advertisements rose 10.7% but the company put some initiatives on hold.

Study shows women view health differently than industry thinks they do

Study shows women view health differently than industry thinks they do

By

A deep dive by the think tank Center for Talent Innovation indicates pharma and payers need to widen their definition of health when communicating with women.

Omnicom reports boost in Q1 net income

The holding company said pharma and health made up 11% of revenues during the first three months of the year.

Patients do not feel connected to pharma

Patients do not feel connected to pharma

By

Wego Health says fixing this problem requires incorporating patient perspectives before and after a product launch.

How to Make DTC Ad 'Warnings' More Effective

How to Make DTC Ad 'Warnings' More Effective

A more general warning encourages consumers to engage in a personal discussion with their doctor about a drug, and it promotes engagement with longer-format printed or digitally-delivered information.

Five things for pharma marketers to know: Friday, March 13

Five things for pharma marketers to know: Friday, March 13

By

J&J sues GlaxoSmithKline over Flonase ads, CDC report finds patients with invasive cancer are living for five years or longer have diagnosis, and Bristol-Myers Squibb resubmits its HCV treatment.

Mobile carries WebMD forward

Mobile carries WebMD forward

By

Smartphones drove network traffic.

AdAge: advertising's penalty box is empty

The Trustworthy Accountability of National Advertisers launched its naming-names initiative in November, but the list is empty.

Five things for pharma marketers to know: Friday, February 20

Five things for pharma marketers to know: Friday, February 20

By

23andMe is back in the DTC game; Sanofi has named its new CEO; drug companies are contemplating a pay-for-performance sales model.

FDA updates DTC ad policy on risk information

FDA updates DTC ad policy on risk information

By

FDA posted a revised draft guidance document on its brief summary and adequate directions for use concerning risk information in DTC print ads to reflect "recent social science research."

OPDP finds many flaws with Luitpold video

OPDP finds many flaws with Luitpold video

By

The list of objections by the Office of Prescription Drug Promotion, which oversees medical advertising, is a familiar one, and includes concerns such as claims that go beyond the approved indication.

Five things for pharma marketers to know: Tuesday, February 10

Five things for pharma marketers to know: Tuesday, February 10

By

FDA's latest guidance says it is ok to reduce the amount of risk information in print ads, Google amplifies the health information it will serve up with searches and HBO's John Oliver takes on pharmaceutical marketing.

Guidemark Health jumpstarts rebrand, brings on big-agency grad

Guidemark Health jumpstarts rebrand, brings on big-agency grad

By

Tina Fascetti is the mid-sized agency's new Chief Creative Officer. CEO Matt Brown (and ICC Lowe alum) tells MM&M the new Guidemark is just getting started.

FDA to study impact of shorter DTC risk list

FDA to study impact of shorter DTC risk list

By

The FDA is looking into whether abbreviated risk information is a good idea for DTC.

Medical Advertising Hall of Fame taps new members

MAHF 2015 Heritage Ad Awards will be given to campaigns for Bentyl, Hytrin and Navane

Ariz. film, entertainment agency adds depth to Fingerpaint

Ariz. film, entertainment agency adds depth to Fingerpaint

By

With the purchase of Olson Communications, the agency aims to serve clients eager for expertise from outside the healthcare industry.

HCB Health lands Alcon AOR

The Austin agency says it beat out FCB, Ogilvy CommonHealth, GSW Worldwide and H4B Chelsea for the work.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.